Eligibility among younger people depends on the vaccine. Moderna’s Spikevax is approved for high-risk patients 6 months and older; the Pfizer-BioNTech vaccine for those 5 and older; and Moderna’s mNexspike and the Novavax vaccine for those 12 and older.
The FDA’s decision is similar to the annual process used to update flu vaccines. FDA advisers reviewed which variants were spreading, how well last year’s vaccines worked, and laboratory evidence showing how the immune system responded to newer variants. The agency said it will continue watching for changes in the virus and monitoring the vaccines’ safety and effectiveness.
The CDC has not issued vaccination recommendations for the 2026-27 season. Its most recent guidance calls for people to decide whether to get a COVID-19 shot based on their age, health risks and consultation with a doctor, nurse or pharmacist.
Will Insurance Cover It?
Because insurance coverage may depend on federal recommendations, people should check with their insurer before making an appointment.
Medicare Part B covers FDA-approved COVID-19 vaccines with no copay when the shots are administered by a participating provider.